Tagged with Cancer

Interview: David Khayat, Head of the Department of Medical Oncology, Pitié-Salpêtrière Hospital, France

Pharma Interview: David Khayat, Head of the Department of Medical Oncology, Pitié-Salpêtrière Hospital, France

Pharma The Head of the Department of Medical Oncology at the Pitié-Salpêtrière Hospital reveals how France is the only country in the world with universal and unlimited access to healthcare, how the oncology world in France is committed to changing the perception of cancer and why the only way to prevent…

Interview: Ahu Yazici – General Manager, BMS, Turkey

Turkey Interview: Ahu Yazici – General Manager, BMS, Turkey

Turkey BMS Turkey’s new general manager discusses Opdivo (nivolumab) their revolutionary new product for squamous non-small cell lung cancer, their registry of 1200 patients in Turkey with melanoma, potential developments in pharmaceutical pricing through alternative reimbursement models, and BMS’ role in helping to shape health policy around oncology given their revolutionary immuno-oncology…

Interview: Noel J. Aymat – Chancellor, UPR Medical Sciences Campus, Puerto Rico

manufacturing Interview: Noel J. Aymat – Chancellor, UPR Medical Sciences Campus, Puerto Rico

manufacturing The chancellor of the Medical Sciences Campus of the University of Puerto Rico discusses the medical R&D projects the university is currently involved in, the fields in which the island has the most potential, and how the institution is tailoring its academic offer to suit the local needs of the…

Interview: Eduardo Payet – Executive Director Epidemiology & Cancer, INEN & Vice President, Peruvian Cancer Foundation – Peru

cancer Interview: Eduardo Payet – Executive Director Epidemiology & Cancer, INEN & Vice President, Peruvian Cancer Foundation – Peru

cancer Eduardo Payet of INEN outlines the institution’s agenda for preventing advanced stages of cancer and plans to expand oncology services beyond Lima to more remote regions of Peru. What is your assessment of the state of cancer in Peru today? Peru is experiencing a demographic and epidemiological transition as a…

Moon Eun-Sang – CEO, SillaJen – South Korea

biotech Moon Eun-Sang – CEO, SillaJen – South Korea

biotech SillaJen’s CEO shares his passion for his companies oncolytic vaccinia virus, and its potential to revolutionize the treatment of solid tumor cancers, even arguing that it may eventually constitute ‘a cure for cancer’. Could you please introduce yourself Dr. Moon, and tell us how you became involved with SillaJen? …

Daehwa Pharmaceutical – Lee Han-Koo, President – South Korea

innovation Daehwa Pharmaceutical – Lee Han-Koo, President – South Korea

innovation Lee Han-Koo, president of Daehwa Pharmaceutical, explains his strategy to corner the transdermal drug delivery system (TDDS) market through innovative patch products as well as a special focus on oral anticancer medication. Could you briefly introduce our readers to Daehwa? Daehwa was founded in January 1984 and listed on the…

Interview: Manuel Hidalgo, Director, CIOCC, Spain

cancer Interview: Manuel Hidalgo, Director, CIOCC, Spain

cancer Manuel Hidalgo, director of the Centro Integral Oncológico Clara Campal (CIOCC), discusses the expansion of the private sector of hospitals in Spain and the latest developments that CIOCC has taken in the area of personalized medicine. How has the quality of healthcare in Spain changed or evolved over the…

DKFZ - German Cancer Research Center Interview with Otmar D Wiestler, Chairman of DKFZ and Vice President of Healmholtz Association, DKFZ – German Cancer Research Center

DKFZ - German Cancer Research Center The DKFZ – German Cancer Research Center – is Germany’s largest cancer research institute with an international recognition recently coroneted with the Nobel Prize to Mr Harald zur Hausen for the HPV vaccine. What were the set of values and visions that allowed the DKEZ to have such a prominent…

1 … 7 8